Acute chest pain (ACP) is a common presenting symptom in clinical practice, posing a diagnostic challenge to clinicians due to its broad differential diagnosis. This article aims to provide a comprehensive approach to evaluating ACP, helping physicians to navigate through this clinical enigma.
The initial assessment should focus on identifying life-threatening conditions. The history should include the PQRST (Provocation, Quality, Region/Radiation, Severity, Timing) elements of pain. A thorough physical examination and an immediate electrocardiogram are essential. High-risk features such as older age, known coronary artery disease, and certain ECG changes should prompt immediate action.
When initial evaluation does not conclusively diagnose the cause of ACP, additional diagnostic testing is necessary. Cardiac biomarkers, chest X-ray, and computed tomography angiography (CTA) are commonly used. Cardiac stress testing and coronary angiography may be considered in certain scenarios. The choice of test should be guided by the pretest probability of disease, patient characteristics, and local resources.
Risk stratification is crucial in the management of ACP. Several validated risk scores exist, such as the TIMI (Thrombolysis in Myocardial Infarction) and GRACE (Global Registry of Acute Coronary Events) scores. These can aid in decision-making regarding the need for hospital admission and the intensity of treatment.
Management of ACP is guided by the underlying cause. For suspected acute coronary syndrome (ACS), early initiation of antiplatelet and anticoagulant therapy is recommended. Non-cardiac causes of ACP should be managed appropriately based on the specific diagnosis.
Evaluating ACP is a complex task requiring a systematic approach. By conducting a thorough initial assessment, utilizing appropriate diagnostic testing, performing risk stratification, and implementing evidence-based management strategies, clinicians can effectively navigate this clinical challenge and optimize patient outcomes.
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation